Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 6/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 5/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.48 |
| ▸ | HDAC9 | Q9UKV0 | 5/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL810020 | 0.86 | NPC1 (0.61) | LTA4HHDAC1HDAC2HDAC3HDAC4 | |
| SCHEMBL831276 | 0.85 | RAB9A (0.61) | LTA4HHDAC8KMT2AMEN1NPC1 | |
| SCHEMBL12534490 | 0.85 | GAA (0.51) | LMNAKMT2AKDM4EMEN1NPC1 | |
| SCHEMBL12810622 | 0.83 | HDAC8 (0.49) | LTA4HHDAC8KMT2AMEN1NPC1 | |
| SCHEMBL25308442 | 0.82 | EPHX2 (0.55) | LTA4HLMNAKMT2AKDM4EMEN1 | |
| SCHEMBL832120 | 0.81 | HDAC8 (0.62) | LTA4HHDAC8KMT2AMEN1NPC1 | |
| SCHEMBL12147930 | 0.80 | EPHX2 (0.53) | LTA4HLMNAKDM4EALDH1A1HTT | |
| SCHEMBL25270797 | 0.80 | HDAC1 (0.66) | LTA4HHDAC1HDAC2HDAC3HDAC4 | |
| SCHEMBL839640 | 0.80 | HDAC1 (0.66) | LTA4HHDAC1HDAC2HDAC3HDAC4 | |
| SCHEMBL10944790 | 0.80 | HDAC1 (0.66) | LTA4HHDAC1HDAC2HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-8372882-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2013-02-12 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2011-06-02 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858077-B2 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-20060173065-A1 | Functionalized phenolic esters and amides and polymers therefrom | BEZWADA BIOMEDICAL LLC | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173065-A1 | Functionalized phenolic esters and amides and polymers therefrom | HAAO, HAO2, HCAR3 | LTA4H 2050/4885HDAC1 255/4885HDAC2 182/4885 |
| US-20110130448-A1 | FUNCTIONALIZED PHENOLIC ESTERS AND AMIDES AND POLYMERS THEREFROM | HAO2, HCAR2, HAAO | LTA4H 2387/4885HDAC1 198/4885HDAC2 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.